Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma

This publication has 14 references indexed in Scilit:

• Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy
  Journal of Neuro-Oncology, 2003
• Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
  JNCI Journal of the National Cancer Institute, 2002
• HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
  Nature Medicine, 1999
• Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1
  International Journal of Cancer, 1999
• The role of Fas/FasL in immunosuppression induced by human tumors
  Cancer Immunology, Immunotherapy, 1998
• Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
  Journal of Immunological Methods, 1998
• Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
  International Journal of Cancer, 1997
• Phenotypic Analysis of Antigen-Specific T Lymphocytes
  Science, 1996
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells
  Journal of Immunological Methods, 1983